METTL3 increases miR-143-3p expression to inhibit protein kinase C ε (PRKCE) transcription to exacerbate cardiomyopathy (CM) firing in MI/reperfusion (MI/R) injury [80]. This evidence concerns the gene METTL3 and cardiomyopathy.